切换至 "中华医学电子期刊资源库"

中华介入放射学电子杂志 ›› 2015, Vol. 03 ›› Issue (03) : 140 -143. doi: 10.3877/cma.j.issn.2095-5782.2015.03.007

所属专题: 文献

肿瘤介入

胸廓内动脉参与肝癌供血介入栓塞后皮肤损伤的发生及预防
宋鹏1, 吴宁1,(), 林福煌1, 李斯锐1, 陈峰1   
  1. 1. 570311 海口,海南省人民医院放射介入科
  • 收稿日期:2014-11-04 出版日期:2015-08-01
  • 通信作者: 吴宁

Skin injury after embolization of ITA participating in blood supply of liver cancer

Peng Song1, Ning Wu1,(), Fuhuang Lin1, Sirui Li1, Feng Chen1   

  1. 1. Department of Interventional Radiology, Hainan General Hospital, Haikou 570311, China
  • Received:2014-11-04 Published:2015-08-01
  • Corresponding author: Ning Wu
  • About author:
    Corresponding author: Wu Ning, Email:
引用本文:

宋鹏, 吴宁, 林福煌, 李斯锐, 陈峰. 胸廓内动脉参与肝癌供血介入栓塞后皮肤损伤的发生及预防[J]. 中华介入放射学电子杂志, 2015, 03(03): 140-143.

Peng Song, Ning Wu, Fuhuang Lin, Sirui Li, Feng Chen. Skin injury after embolization of ITA participating in blood supply of liver cancer[J]. Chinese Journal of Interventional Radiology(Electronic Edition), 2015, 03(03): 140-143.

目的

探讨胸廓内动脉(ITA)参与肝癌供血行介入栓塞治疗后皮肤损伤的发生特点及预防措施。

方法

对26例经血管造影确认有ITA参与肝癌供血者行ITA栓塞治疗。26例患者既往行TACE治疗2~6次,5例有肝切除病史。其中16例用碘油-抗癌药物乳剂栓塞,10例用碘化油及明胶海绵颗粒进行栓塞。8例用微导管行超选择性肿瘤供血动脉栓塞。术后观察并随访患者前胸壁及肝区皮肤变化。

结果

26例患者ITA参与肝癌供血者,右侧ITA 24例,左侧ITA 3例。19例介入治疗后出现不同程度前胸壁及肝区皮肤灼热感或针刺样疼痛。5例出现明显皮肤损伤,其中3例损伤皮肤出现破溃,1例继发感染。5例患者均应用碘油-抗癌药物乳剂行非选择性ITA栓塞。随诊1~4个月后5例均结痂愈合。

结论

皮肤损伤是经导管介入栓塞ITA的常见并发症,应用碘油-抗癌药物乳剂非选择性栓塞ITA是造成皮肤损伤的主要原因。

Objective

To explore the characteristics and the preventive measures of skin injury after interventional embolization of internal thoracic artery (ITA) participating in the blood supply of liver cancer.

Methods

ITA embolization was performed in 26 hepatic carcinoma patients confirmed to be the tumor blood supply arteries by angiography. All of the 26 patients had received TACE treatment for 2 to 6 times, and 5 of them had received liver resection. A total of 16 patients received ITA embolization by lipiodol antineoplastic emulsion, but lipiodol and Gelfoam were used in the other 10 patients. Eight cases received super selective embolization with micro-catheter. Observe and follow-up the change of the anterior chest wall skin.

Results

Twenty-four of the 26 patients received RITA embolization, 3 received LITA embolization, and 1 patient received both RITA and LITA embolization. After interventional therapy, 19 patients experienced different degree of burning sense and stabbing pain in the skin of anterior chest wall and liver area. Obvious skin injury occurred in 5 cases, and 3 of them appeared damaged skin rupture, and 1 case got secondary infection. All of the 5 patients got non-selective ITA embolization with lipiodol antineoplastic emulsion, and they all healed in 1—4 months.

Conclusions

Non-selective ITA embolization with lipiodol antineoplastic emulsion is the main cause of the skin damage.

图1 患者男,47岁,肝癌,既往行4次TACE,RITA造影可见肝内多发肿瘤染色(箭,A),用碘油-抗癌药物乳剂行非超选择性栓塞治疗后第6天,肝区可见明显的皮肤损伤(箭,B)局部伴有水泡
图2 患者男,53岁,肝癌,既往行3次TACE,LITA造影可见肝内肿瘤染色(箭,A),将同轴微导管超选择性插至肿瘤供血分支(肌膈动脉,箭)行超选择性栓塞治疗后,病变碘油聚集良好(箭,B),术后未见皮肤损伤
表1 不同栓塞技术皮肤损伤统计
1
Paul SB, Gamanagatti SR, Mukund A, et al. Transarterial chemoembolization for hepatocellular carcinoma: significance of extrahepatic collateral supply[J]. Indian J Cancer, 2011,48(3):339-344.
2
Miyayama S, Matsui O, Taki K, et al. Extrahepatic blood supply to hepatocellular carcinoma: angiographic demonstration and transcatheter arterial chemoembolization[J]. Cardiovasc Intervent Radiol, 2006,29(1):39-48.
3
Wang YL, Li MH, Cheng YS, et al. Influential factors and formation of extrahepatic collateral artery in unresectable hepatocellular carcinoma[J]. World J Gastroenterol, 2005,11(17):2637-2642.
4
Fan QS, Huo XK, Wang MQ, et al. Efficacy and safety of transcatheter chemo- embolization of the internal thoracic artery in patients with hepatocellular carcinoma[J]. Chin Med J (Engl), 2011,124(9):1374-1380.
5
Nakai M, Sato M, Kawai N, et al. Hepatocellular carcinoma: involvement of the internal mammary artery[J]. Radiology, 2001,219(1):147-152.
6
王茂强,张金山,高育傲.胸廓内动脉参与肝脏肿瘤供血的影像表现与介入治疗(附6例报告)[J]. 临床放射学杂志,1998,17(1):47-49.
7
李强,王茂强,宋鹏,等.内乳动脉参与肝癌供血的介入治疗[J].介人放射学杂志,2007,16(12):816-819.
8
Jonsson K, Karlsson S. Angiography of the internal mammary artery[J]. Acta Radiol, 1985,26(2):113-120.
9
Baba Y, Hokotate H, Nakajo M. Visualization of the internal mammary artery via the hepatic falciform artery in a patient with hepatocellular carcinoma[J]. Acta Radiol, 2004,45(7):716-717.
10
Kim HC, Chung JW, Choi SH, et al. Hepatocellular carcinoma with internal mammary artery supply: feasibility and efficacy of transarterial chemoembolization and factors affecting patient prognosis[J]. J Vasc Interv Radiol, 2007,18(5):611-619.
11
Kim SH, Kim HC, Hur S, et al. Chemoembolization via the left internal mammary artery supplying hepatocellular carcinoma[J]. J Vasc Interv Radiol, 2014,25(9):1389-1397.
12
Kanetsuki I, Hori A, Ohshiro K, et al. Left lobe recurrent hepatocellular carcinoma treated with lipiodol-TAE via the left internal mammary artery[J]. Cardiovasc Intervent Radiol,1997,20(5):387-389.
13
Miyayama S, Yamashiro M, Hashimoto M, et al. Clinical features of hepato- cellular carcinoma supplied by the left internal mammary artery[J]. Jpn J Radiol, 2012,30(10):798-805.
14
Miyayama S, Yamashiro M, Shibata Y, et al. Variations in feeding arteries of hepatocellular carcinoma located in the left hepatic lobe[J]. Jpn J Radiol, 2012,30(6):471-479.
15
Zhang J, Hu J, Xia P, et al. Spinal complication after transcatheter arterial chemo- embolization via right internal mammary artery in a patient with hepatocellular carcinoma[J]. J Vasc Interv Radiol, 2013,24(12):1930-1932.
16
Kajiwara K, Kakizawa H, Takeuchi N, et al. Cutaneous complications after trans- catheter arterial treatment for hepatocellular carcinoma via the internal mammary artery: how to avoid this complication[J]. Jpn J Radiol, 2011,29(5):307-315.
17
Lee JH, Chon CY, Ahn SH, et al. An ischemic skin lesion after chemo- embolization of the right internal mammary artery in a patient with hepatocellular carcinoma[J]. Yonsei Med J, 2001,42(1):137-141.
[1] 韩丹, 王婷, 肖欢, 朱丽容, 陈镜宇, 唐毅. 超声造影与增强CT对儿童肝脏良恶性病变诊断价值的对比分析[J]. 中华医学超声杂志(电子版), 2023, 20(09): 939-944.
[2] 韩李念, 王君. 放射性皮肤损伤治疗的研究进展[J]. 中华损伤与修复杂志(电子版), 2023, 18(06): 533-537.
[3] 李建美, 邓静娟, 杨倩. 两种术式联合治疗肝癌合并肝硬化门静脉高压的安全性及随访评价[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 41-44.
[4] 陈忠垚, 陈胜灯, 李秋. 不同手术时机对原发性肝癌自发破裂出血患者远期预后的影响[J]. 中华普外科手术学杂志(电子版), 2023, 17(05): 518-521.
[5] 孟令展, 朱震宇. 达芬奇机器人辅助肝中叶切除术[J]. 中华普外科手术学杂志(电子版), 2023, 17(04): 373-373.
[6] 杜锡林, 谭凯, 贺小军, 白亮亮, 赵瑶瑶. 肝细胞癌转化治疗方式[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 597-601.
[7] 唐灿, 李向阳, 秦浩然, 李婧, 王天云, 柯阳, 朱红. 原发性肝脏神经内分泌肿瘤单中心12例诊治与疗效分析[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 674-680.
[8] 崔佳琪, 吴迪, 陈海艳, 周惠敏, 顾元龙, 周光文, 杨军. TACE术后并发肝脓肿的临床诊治分析[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 688-693.
[9] 韩冰, 顾劲扬. 深度学习神经网络在肝癌诊疗中的研究及应用前景[J]. 中华肝脏外科手术学电子杂志, 2023, 12(05): 480-485.
[10] 何传超, 肖治宇. 晚期肝癌综合治疗模式与策略[J]. 中华肝脏外科手术学电子杂志, 2023, 12(05): 486-489.
[11] 王楚风, 蒋安. 原发性肝癌的分子诊断[J]. 中华肝脏外科手术学电子杂志, 2023, 12(05): 499-503.
[12] 顾娇娇, 邹燕, 陈奕辰, 黄师菊, 张慧玲, 林楠. 基于简易营养评价精法评估肝癌患者出院后营养状况及其影响因素[J]. 中华肝脏外科手术学电子杂志, 2023, 12(05): 534-539.
[13] 孟令展, 李虎, 俞鹏, 于燕宾, 曹李, 翟伟, 高远, 邵艳玲, 严锦, 朱震宇. ICG荧光染色在肝癌腹腔镜解剖性肝切除术中的应用[J]. 中华肝脏外科手术学电子杂志, 2023, 12(05): 557-561.
[14] 赫嵘, 贾哲, 张珂, 李代京, 张萌, 蒋力. 基于PSM分析腹腔镜肝切除联合Hassab术治疗合并门静脉高压症肝癌疗效[J]. 中华肝脏外科手术学电子杂志, 2023, 12(04): 376-383.
[15] 杨发才, 游川, 雷正清, 李伟男, 段安琪, 邱应和, 李敬东, 程张军. 肿瘤负荷评分联合淋巴结分期对肝内胆管细胞癌患者术后生存预测价值[J]. 中华肝脏外科手术学电子杂志, 2023, 12(04): 389-394.
阅读次数
全文


摘要